Tardive Dyskinesia Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: T859489344F7EN
Market Monitor Global

Abstracts

Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.

This report contains market size and forecasts of Tardive Dyskinesia in Global, including the following market information:

Global Tardive Dyskinesia Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tardive Dyskinesia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dopamine-Depleting Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tardive Dyskinesia include Bausch Health, Neurocrine Biosciences and Teva Pharmaceuticals Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tardive Dyskinesia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tardive Dyskinesia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tardive Dyskinesia Market Segment Percentages, by Type, 2021 (%)

• Dopamine-Depleting Medications
• GABA Receptor Agonist Medications
• Anticholinergic Medications

Global Tardive Dyskinesia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tardive Dyskinesia Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Tardive Dyskinesia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tardive Dyskinesia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tardive Dyskinesia revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tardive Dyskinesia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bausch Health
• Neurocrine Biosciences
• Teva Pharmaceuticals Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tardive Dyskinesia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tardive Dyskinesia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TARDIVE DYSKINESIA OVERALL MARKET SIZE

2.1 Global Tardive Dyskinesia Market Size: 2021 VS 2028
2.2 Global Tardive Dyskinesia Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tardive Dyskinesia Players in Global Market
3.2 Top Global Tardive Dyskinesia Companies Ranked by Revenue
3.3 Global Tardive Dyskinesia Revenue by Companies
3.4 Top 3 and Top 5 Tardive Dyskinesia Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tardive Dyskinesia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tardive Dyskinesia Players in Global Market
  3.6.1 List of Global Tier 1 Tardive Dyskinesia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tardive Dyskinesia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tardive Dyskinesia Market Size Markets, 2021 & 2028
  4.1.2 Dopamine-Depleting Medications
  4.1.3 GABA Receptor Agonist Medications
  4.1.4 Anticholinergic Medications
4.2 By Type - Global Tardive Dyskinesia Revenue & Forecasts
  4.2.1 By Type - Global Tardive Dyskinesia Revenue, 2017-2022
  4.2.2 By Type - Global Tardive Dyskinesia Revenue, 2023-2028
  4.2.3 By Type - Global Tardive Dyskinesia Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tardive Dyskinesia Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Centers
5.2 By Application - Global Tardive Dyskinesia Revenue & Forecasts
  5.2.1 By Application - Global Tardive Dyskinesia Revenue, 2017-2022
  5.2.2 By Application - Global Tardive Dyskinesia Revenue, 2023-2028
  5.2.3 By Application - Global Tardive Dyskinesia Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tardive Dyskinesia Market Size, 2021 & 2028
6.2 By Region - Global Tardive Dyskinesia Revenue & Forecasts
  6.2.1 By Region - Global Tardive Dyskinesia Revenue, 2017-2022
  6.2.2 By Region - Global Tardive Dyskinesia Revenue, 2023-2028
  6.2.3 By Region - Global Tardive Dyskinesia Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tardive Dyskinesia Revenue, 2017-2028
  6.3.2 US Tardive Dyskinesia Market Size, 2017-2028
  6.3.3 Canada Tardive Dyskinesia Market Size, 2017-2028
  6.3.4 Mexico Tardive Dyskinesia Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tardive Dyskinesia Revenue, 2017-2028
  6.4.2 Germany Tardive Dyskinesia Market Size, 2017-2028
  6.4.3 France Tardive Dyskinesia Market Size, 2017-2028
  6.4.4 U.K. Tardive Dyskinesia Market Size, 2017-2028
  6.4.5 Italy Tardive Dyskinesia Market Size, 2017-2028
  6.4.6 Russia Tardive Dyskinesia Market Size, 2017-2028
  6.4.7 Nordic Countries Tardive Dyskinesia Market Size, 2017-2028
  6.4.8 Benelux Tardive Dyskinesia Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tardive Dyskinesia Revenue, 2017-2028
  6.5.2 China Tardive Dyskinesia Market Size, 2017-2028
  6.5.3 Japan Tardive Dyskinesia Market Size, 2017-2028
  6.5.4 South Korea Tardive Dyskinesia Market Size, 2017-2028
  6.5.5 Southeast Asia Tardive Dyskinesia Market Size, 2017-2028
  6.5.6 India Tardive Dyskinesia Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tardive Dyskinesia Revenue, 2017-2028
  6.6.2 Brazil Tardive Dyskinesia Market Size, 2017-2028
  6.6.3 Argentina Tardive Dyskinesia Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tardive Dyskinesia Revenue, 2017-2028
  6.7.2 Turkey Tardive Dyskinesia Market Size, 2017-2028
  6.7.3 Israel Tardive Dyskinesia Market Size, 2017-2028
  6.7.4 Saudi Arabia Tardive Dyskinesia Market Size, 2017-2028
  6.7.5 UAE Tardive Dyskinesia Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bausch Health
  7.1.1 Bausch Health Corporate Summary
  7.1.2 Bausch Health Business Overview
  7.1.3 Bausch Health Tardive Dyskinesia Major Product Offerings
  7.1.4 Bausch Health Tardive Dyskinesia Revenue in Global Market (2017-2022)
  7.1.5 Bausch Health Key News
7.2 Neurocrine Biosciences
  7.2.1 Neurocrine Biosciences Corporate Summary
  7.2.2 Neurocrine Biosciences Business Overview
  7.2.3 Neurocrine Biosciences Tardive Dyskinesia Major Product Offerings
  7.2.4 Neurocrine Biosciences Tardive Dyskinesia Revenue in Global Market (2017-2022)
  7.2.5 Neurocrine Biosciences Key News
7.3 Teva Pharmaceuticals Industries
  7.3.1 Teva Pharmaceuticals Industries Corporate Summary
  7.3.2 Teva Pharmaceuticals Industries Business Overview
  7.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Major Product Offerings
  7.3.4 Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue in Global Market (2017-2022)
  7.3.5 Teva Pharmaceuticals Industries Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tardive Dyskinesia Market Opportunities & Trends in Global Market
Table 2. Tardive Dyskinesia Market Drivers in Global Market
Table 3. Tardive Dyskinesia Market Restraints in Global Market
Table 4. Key Players of Tardive Dyskinesia in Global Market
Table 5. Top Tardive Dyskinesia Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tardive Dyskinesia Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tardive Dyskinesia Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tardive Dyskinesia Product Type
Table 9. List of Global Tier 1 Tardive Dyskinesia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tardive Dyskinesia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tardive Dyskinesia Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tardive Dyskinesia Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tardive Dyskinesia Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tardive Dyskinesia Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tardive Dyskinesia Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tardive Dyskinesia Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tardive Dyskinesia Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tardive Dyskinesia Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tardive Dyskinesia Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tardive Dyskinesia Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tardive Dyskinesia Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tardive Dyskinesia Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tardive Dyskinesia Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tardive Dyskinesia Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tardive Dyskinesia Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tardive Dyskinesia Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tardive Dyskinesia Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tardive Dyskinesia Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tardive Dyskinesia Revenue, (US$, Mn), 2023-2028
Table 30. Bausch Health Corporate Summary
Table 31. Bausch Health Tardive Dyskinesia Product Offerings
Table 32. Bausch Health Tardive Dyskinesia Revenue (US$, Mn), (2017-2022)
Table 33. Neurocrine Biosciences Corporate Summary
Table 34. Neurocrine Biosciences Tardive Dyskinesia Product Offerings
Table 35. Neurocrine Biosciences Tardive Dyskinesia Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceuticals Industries Corporate Summary
Table 37. Teva Pharmaceuticals Industries Tardive Dyskinesia Product Offerings
Table 38. Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tardive Dyskinesia Segment by Type in 2021
Figure 2. Tardive Dyskinesia Segment by Application in 2021
Figure 3. Global Tardive Dyskinesia Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tardive Dyskinesia Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tardive Dyskinesia Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tardive Dyskinesia Revenue in 2021
Figure 8. By Type - Global Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 12. US Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 16. Germany Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 17. France Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 24. China Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 28. India Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 30. Brazil Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tardive Dyskinesia Revenue Market Share, 2017-2028
Figure 33. Turkey Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tardive Dyskinesia Revenue, (US$, Mn), 2017-2028
Figure 37. Bausch Health Tardive Dyskinesia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Neurocrine Biosciences Tardive Dyskinesia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)